Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julia Roux"'
Publikováno v:
Indian Journal of Pediatrics. 90:311-311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84a4409173d684d73ab91709bdcc6398
https://doi.org/10.1007/s12098-022-04443-2
https://doi.org/10.1007/s12098-022-04443-2
Autor:
Aurélien Amiot, Guillaume Bouguen, Guillaume Bonnaud, Yoram Bouhnik, Hervé Hagege, Laurent Peyrin-Biroulet, Vered Abitbol, Georgia Malamut, Aurelien Amiot, Arnaud Boruchowicz, Laurent Siproudhis, Marie DeWitte, Carmen Stefanescu, Anthony Buisson, Ludovic Caillo, Maryan Cavicchi, Nina Dib, Isabelle Etienney, Jerome Filippi, Mathurin Fumery, Felix Goutorbe, Laurent Costes, Mathias Vidon, Frédéric Heluwaert, Christophe Locher, Mehdi Kaassis, Patrick Mamou, Chloe MARTINEAU, Nicolas Mathieu, Benjamin Pariente, Pauline WILS, Stephane Nancey, Magalie Picon-Coste, Camille Zallot, Marie-Pierre Pingannaud, Xavier Roblin, Julia Roux, Melanie Serrero, Marion Simon, Florence Skinazi, Lucas Spindler, Stephanie Viennot
Publikováno v:
Digestive and Liver Disease
Digestive and Liver Disease, 2021, 53 (1), pp.35-43. ⟨10.1016/j.dld.2020.10.018⟩
Digestive and Liver Disease, WB Saunders, 2021, 53 (1), pp.35-43. ⟨10.1016/j.dld.2020.10.018⟩
Digestive and Liver Disease, Elsevier, 2021, 53 (1), pp.35-43. ⟨10.1016/j.dld.2020.10.018⟩
Digestive and Liver Disease, 2021, 53 (1), pp.35-43. ⟨10.1016/j.dld.2020.10.018⟩
Digestive and Liver Disease, WB Saunders, 2021, 53 (1), pp.35-43. ⟨10.1016/j.dld.2020.10.018⟩
Digestive and Liver Disease, Elsevier, 2021, 53 (1), pp.35-43. ⟨10.1016/j.dld.2020.10.018⟩
International audience; BACKGROUND: New treatments and therapeutic approaches repeatedly emerged in the field of inflammatory bowel disease. AIM: to update the French treatment algorithms for Crohn’s disease (CD) and ulcerative colitis (UC). METHOD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49d9c4f1dd8026690c2452b7df814d7
https://hal.science/hal-03001613
https://hal.science/hal-03001613
Autor:
Pascal Hammel, Sandrine Faivre, Thierry André, Aimery de Gramont, Benoist Chibaudel, Sihem Sebbagh, Olivia Hentic, Cecilia Orbegoso, Julia Roux, Eric Raymond, Armand de Gramont, Chantal Dreyer, Cindy Neuzillet
Publikováno v:
Acta Oncologica. 55:1168-1174
Gemcitabine (GEM)-platinum chemotherapy stands as first-line therapy for patients with recurrent/advanced biliary tract cancer (BTC), yielding progression-free survival (PFS) of 3.4-6.4 months. No standard second-line chemotherapy after GEM-platinum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9ecf371b20c569ba568067fc3a1453
https://doi.org/10.1080/0284186x.2016.1191670
https://doi.org/10.1080/0284186x.2016.1191670